Adaptive Biotechnologies(ADPT) - 2023 Q2 - Earnings Call Transcript

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q2 2023 Results Conference Call August 2, 2023 4:30 PM ET Company Participants Karina Calzadilla - Head, IR Chad Robins - CEO and Co-founder Tycho Peterson - CFO Nitin Sood - Chief Commercial Officer, MRD Harlan Robins - Chief Scientific Officer and Co-founder Sharon Benzeno - Chief Commercial Officer, Immune Medicine Conference Call Participants Rachel Vatnsdal - JPMorgan Chase Dan Brennan - TD Cowen David Westenberg - Piper Sandler Mark Massaro - BTIG Eli ...